CCT8L2
gene geneOn this page
Also known as CESK1
Summary
CCT8L2 (chaperonin containing TCP1 subunit 8 like 2, HGNC:15553) is a protein-coding gene on chromosome 22q11.1, encoding T-complex protein 1 subunit theta-like 2 (Q96SF2). Possible molecular chaperone; assists the folding of proteins upon ATP hydrolysis.
Predicted to enable unfolded protein binding activity. Predicted to be involved in protein folding. Predicted to be located in cytoplasm. Predicted to be part of chaperonin-containing T-complex.
Source: NCBI Gene 150160 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 108 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_014406
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15553 |
| Approved symbol | CCT8L2 |
| Name | chaperonin containing TCP1 subunit 8 like 2 |
| Location | 22q11.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CESK1 |
| Ensembl gene | ENSG00000198445 |
| Ensembl biotype | protein_coding |
| Entrez | 150160 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000359963
RefSeq mRNA: 1 — MANE Select: NM_014406
NM_014406
CCDS: CCDS13738
Canonical transcript exons
ENST00000359963 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001806026 | 16590751 | 16592810 |
Expression profiles
Bgee: expression breadth broad, 14 present calls, max score 83.24.
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.24 | gold quality |
| right testis | UBERON:0004534 | 79.87 | gold quality |
| left testis | UBERON:0004533 | 79.81 | gold quality |
| testis | UBERON:0000473 | 76.93 | gold quality |
| male germ cell | CL:0000015 | 55.43 | gold quality |
| sperm | CL:0000019 | 55.04 | gold quality |
| buccal mucosa cell | CL:0002336 | 52.71 | gold quality |
| pancreatic ductal cell | CL:0002079 | 49.68 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 49.41 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| adult organism | UBERON:0007023 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.92 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.00 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 47.45 | gold quality |
| thymus | UBERON:0002370 | 47.42 | gold quality |
| kidney epithelium | UBERON:0004819 | 47.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting CCT8L2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-4470 | 99.66 | 69.35 | 1767 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-5088-3P | 98.29 | 66.63 | 1310 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-146B-3P | 97.83 | 65.29 | 782 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-339-5P | 96.73 | 66.01 | 820 |
| HSA-MIR-642B-5P | 96.37 | 67.26 | 745 |
| HSA-MIR-624-5P | 96.00 | 68.88 | 728 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cct8l1 | ENSMUSG00000038044 |
| rattus_norvegicus | Cct8l2 | ENSRNOG00000047114 |
Paralogs (13): PIKFYVE (ENSG00000115020), CCT4 (ENSG00000115484), TCP1 (ENSG00000120438), MKKS (ENSG00000125863), CCT6B (ENSG00000132141), CCT7 (ENSG00000135624), HSPD1 (ENSG00000144381), CCT6A (ENSG00000146731), CCT5 (ENSG00000150753), CCT8 (ENSG00000156261), CCT3 (ENSG00000163468), CCT2 (ENSG00000166226), BBS12 (ENSG00000181004)
Protein
Protein identifiers
T-complex protein 1 subunit theta-like 2 — Q96SF2 (reviewed: Q96SF2)
Alternative names: Chaperonin containing T-complex polypeptide 1 subunit 8-like 2
All UniProt accessions (1): Q96SF2
UniProt curated annotations — full annotation on UniProt →
Function. Possible molecular chaperone; assists the folding of proteins upon ATP hydrolysis.
Subcellular location. Cytoplasm.
Miscellaneous. Presence of two highly similar CCT8L genes (CCT8L1P and CCT8L2) in the genomes of human and chimp and of a single copy in other mammal genomes, including rhesus monkey, suggests that the duplication of this gene occurred in the ape lineage (Hominoidea) after its divergence from the old-world monkeys (Cercopithecidae). Expression of CCT8L2 is confirmed by many ESTs mostly identified from the testis.
Similarity. Belongs to the TCP-1 chaperonin family.
RefSeq proteins (1): NP_055221* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002423 | Cpn60/GroEL/TCP-1 | Family |
| IPR017998 | TCP-1 | Family |
| IPR027409 | GroEL-like_apical_dom_sf | Homologous_superfamily |
| IPR027410 | TCP-1-like_intermed_sf | Homologous_superfamily |
| IPR027413 | GROEL-like_equatorial_sf | Homologous_superfamily |
Pfam: PF00118
UniProt features (4 total): region of interest 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96SF2-F1 | 84.62 | 0.62 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 70 (showing top):
GOBP_POTASSIUM_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_PROTEIN_MATURATION, GOBP_PROTEIN_FOLDING, GOBP_TRANSMEMBRANE_TRANSPORT, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOMF_UNFOLDED_PROTEIN_BINDING, GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_GATED_CHANNEL_ACTIVITY, GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY, GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_POTASSIUM_CHANNEL_ACTIVITY
GO Biological Process (3): protein folding (GO:0006457), potassium ion transmembrane transport (GO:0071805), monoatomic anion transmembrane transport (GO:0098656)
GO Molecular Function (6): monoatomic anion channel activity (GO:0005253), ATP binding (GO:0005524), calcium-activated potassium channel activity (GO:0015269), obsolete unfolded protein binding (GO:0051082), ATP-dependent protein folding chaperone (GO:0140662), nucleotide binding (GO:0000166)
GO Cellular Component (2): chaperonin-containing T-complex (GO:0005832), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 1 |
| protein maturation | 1 |
| potassium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| monoatomic anion transport | 1 |
| monoatomic ion transmembrane transport | 1 |
| monoatomic ion channel activity | 1 |
| monoatomic anion transmembrane transporter activity | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| calcium-activated cation channel activity | 1 |
| potassium channel activity | 1 |
| protein folding chaperone | 1 |
| ATP-dependent activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| cytosol | 1 |
| protein folding chaperone complex | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1307 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCT8L2 | LRRC74B | Q6ZQY2 | 571 |
| CCT8L2 | RIMBP3C | A6NJZ7 | 526 |
| CCT8L2 | GAB4 | Q2WGN9 | 517 |
| CCT8L2 | BBS10 | Q8TAM1 | 480 |
| CCT8L2 | C11orf87 | Q6NUJ2 | 479 |
| CCT8L2 | OR5W2 | Q8NH69 | 479 |
| CCT8L2 | Q6GMV1 | Q6GMV1 | 448 |
| CCT8L2 | POTEH | Q6S545 | 425 |
| CCT8L2 | XKR3 | Q5GH77 | 396 |
| CCT8L2 | LRRIQ1 | Q96JM4 | 395 |
| CCT8L2 | C14orf132 | Q9NPU4 | 391 |
| CCT8L2 | CCT3 | P49368 | 385 |
| CCT8L2 | PI4KA | P42356 | 379 |
| CCT8L2 | LZTR1 | Q8N653 | 378 |
| CCT8L2 | SERPIND1 | P05546 | 371 |
| CCT8L2 | TMEM150B | A6NC51 | 371 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCT8L2 | ACSL4 | psi-mi:“MI:0914”(association) | 0.530 |
| CCT8L2 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| CCT8L2 | DVL2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (156): SATB2 (Affinity Capture-MS), MPP2 (Affinity Capture-MS), PLEKHG4 (Affinity Capture-MS), SPEN (Affinity Capture-MS), ANKS1A (Affinity Capture-MS), CAMK2D (Affinity Capture-MS), FBXO7 (Affinity Capture-MS), MAPRE2 (Affinity Capture-MS), IKBKB (Affinity Capture-MS), SKP2 (Affinity Capture-MS), DVL2 (Affinity Capture-MS), PEX6 (Affinity Capture-MS), CHUK (Affinity Capture-MS), TXNIP (Affinity Capture-MS), CIZ1 (Affinity Capture-MS)
ESM2 similar proteins: A0A193KX02, A0A5F8AH41, A1Y9I9, A4FUH1, A6NM43, A7YY46, B6CZ46, B6CZ56, B6CZ62, D3ZBP4, D3ZX08, E9QAM5, H9TB19, O43542, P10937, P11086, P40935, P41226, P55205, P86243, Q14CH7, Q2M296, Q32Q92, Q3URQ7, Q3V1F8, Q3ZBE0, Q53S58, Q5E9L5, Q5JTZ9, Q5JU69, Q5M936, Q5SS80, Q5XIL6, Q69ZP3, Q6AYR4, Q6NZB1, Q6ZSI9, Q80YU0, Q8N490, Q8R1J9
Diamond homologs: A0QKR2, A5FPR4, A6NM43, A8EY36, A8YTH8, A9NHL6, B2V8F1, B7H4Q7, B7IUT0, O68324, P42932, P50990, P60545, Q048Y3, Q1G937, Q29068, Q3AUZ9, Q3Z6L3, Q3ZCI9, Q4MPR6, Q4R5J0, Q5RAP1, Q6EE31, Q814B0, Q8R5T7, Q93G07, Q96SF2, Q9KJ23, A0A0K0XCY8, A8X6I9, O15891, O24730, O24731, O24732, O24734, O24735, O26320, O26885, O28045, O28821
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
108 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 96 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 59275 | GRCh38/hg38 22q11.1-11.21(chr22:11121452-18167952)x3 | Pathogenic |
| 980799 | GRCh37/hg19 22q11.1(chr22:16888899-17536145)x4 | Likely pathogenic |
SpliceAI
17 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:16591973:T:TA | donor_gain | 0.3800 |
| 22:16591845:A:C | donor_gain | 0.3100 |
| 22:16591516:G:A | donor_gain | 0.2900 |
| 22:16591732:T:TA | donor_gain | 0.2900 |
| 22:16591843:TAAC:T | donor_gain | 0.2500 |
| 22:16591844:AACA:A | donor_gain | 0.2500 |
| 22:16591843:TA:T | donor_gain | 0.2400 |
| 22:16591844:AA:A | donor_gain | 0.2400 |
| 22:16592213:T:TA | donor_gain | 0.2400 |
| 22:16592258:G:GA | donor_gain | 0.2400 |
| 22:16591607:A:AC | donor_gain | 0.2300 |
| 22:16591601:G:C | donor_gain | 0.2100 |
| 22:16592277:C:A | donor_gain | 0.2100 |
| 22:16591807:A:T | acceptor_gain | 0.2000 |
| 22:16591873:C:A | donor_gain | 0.2000 |
| 22:16592145:AGG:A | donor_gain | 0.2000 |
| 22:16592555:C:CT | acceptor_gain | 0.2000 |
AlphaMissense
3575 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:16591051:T:A | K500N | 0.968 |
| 22:16591051:T:G | K500N | 0.968 |
| 22:16591228:A:C | F441L | 0.962 |
| 22:16591228:A:T | F441L | 0.962 |
| 22:16591230:A:G | F441L | 0.962 |
| 22:16591068:C:G | D495H | 0.954 |
| 22:16591462:A:C | F363L | 0.946 |
| 22:16591462:A:T | F363L | 0.946 |
| 22:16591464:A:G | F363L | 0.946 |
| 22:16591987:G:C | C188W | 0.945 |
| 22:16591463:A:G | F363S | 0.941 |
| 22:16591512:A:G | C347R | 0.941 |
| 22:16592196:C:G | A119P | 0.941 |
| 22:16591052:T:A | K500I | 0.940 |
| 22:16591502:A:T | V350D | 0.940 |
| 22:16591067:T:A | D495V | 0.938 |
| 22:16591010:A:G | L514P | 0.936 |
| 22:16591670:A:T | V294E | 0.936 |
| 22:16591067:T:G | D495A | 0.935 |
| 22:16591807:A:C | F248L | 0.933 |
| 22:16591807:A:T | F248L | 0.933 |
| 22:16591809:A:G | F248L | 0.933 |
| 22:16591741:A:C | F270L | 0.932 |
| 22:16591741:A:T | F270L | 0.932 |
| 22:16591743:A:G | F270L | 0.932 |
| 22:16591957:G:C | F198L | 0.932 |
| 22:16591957:G:T | F198L | 0.932 |
| 22:16591959:A:G | F198L | 0.932 |
| 22:16591185:C:G | A456P | 0.931 |
| 22:16591430:G:A | T374I | 0.931 |
dbSNP variants (sampled 300 via entrez): RS1000946370 (22:16593021 G>A), RS1002942513 (22:16590686 G>A), RS1003147181 (22:16590534 T>C), RS1003382916 (22:16594437 A>G), RS1005009023 (22:16593110 C>G), RS1005464556 (22:16593280 G>A), RS1008854177 (22:16593626 T>A), RS1008906636 (22:16593960 G>A,C,T), RS1011205870 (22:16590296 C>A,T), RS1011716895 (22:16590489 G>A), RS1012158297 (22:16594186 G>A,T), RS1013814502 (22:16593088 C>T), RS1014685973 (22:16594224 A>C), RS1015150585 (22:16594440 T>G), RS1016674568 (22:16591994 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002112_8 | Celiac disease | 5.000000e-06 |
| GCST008758_86 | Pre-treatment viral load in HIV-1 infection | 4.000000e-16 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010125 | viral load |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): celiac disease